{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:29:57Z","timestamp":1790429397499,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41375-019-0499-4","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T15:02:26Z","timestamp":1561129346000},"page":"2254-2265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Quality control and quantification in IG\/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS"],"prefix":"10.1038","volume":"33","author":[{"name":"on behalf of the EuroClonality-NGS Working Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Knecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Reigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-1072","authenticated-orcid":false,"given":"Michaela","family":"Kotrov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Appelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Bystry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Grioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Stranska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Plevova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Rijntjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Songia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Svato\u0148","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fro\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-2787","authenticated-orcid":false,"given":"Ram\u00f3n","family":"Garc\u00eda-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-3531","authenticated-orcid":false,"given":"John","family":"Moppett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-4528","authenticated-orcid":false,"given":"Giovanni","family":"Cazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J. T. A.","family":"Groenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Darzentas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1053\/j.seminhematol.2011.05.002","volume":"48","author":"C Pott","year":"2011","unstructured":"Pott C. Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance. Semin Hematol. 2011;48:172\u201384.","journal-title":"Semin Hematol"},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hon.989","volume":"29","author":"S Ferrero","year":"2011","unstructured":"Ferrero S, Drandi D, Mantoan B, Ghione P, Omed\u00e8 P, Ladetto M. Minimal residual disease detection in lymphoma and multiple myeloma: Impact on therapeutic paradigms. Hematol Oncol. 2011;29:167\u201376.","journal-title":"Hematol Oncol"},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.seminoncol.2011.11.009","volume":"39","author":"M Br\u00fcggemann","year":"2012","unstructured":"Br\u00fcggemann M, G\u00f6kbuget N, Kneba M. Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle. Semin Oncol. 2012;39:47\u201357.","journal-title":"Semin Oncol"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1182\/blood-2012-06-379040","volume":"120","author":"M Br\u00fcggemann","year":"2012","unstructured":"Br\u00fcggemann M, Raff T, Kneba M. Has MRD monitoring superseded other prognostic factors in adult ALL? Blood. 2012;120:4470\u201381.","journal-title":"Blood"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM Van Dongen","year":"1998","unstructured":"Van Dongen JJM, Seriu T, Panzer-Gr\u00fcmayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731\u20138.","journal-title":"Lancet"},{"issue":"1","key":"499_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/asheducation-2017.1.13","volume":"2017","author":"Monika Br\u00fcggemann","year":"2017","unstructured":"Br\u00fcggemann M, Kotrova M. Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. Hematol Am Soc Hematol Educ Progr. 2017;2017(1):13\u201321.","journal-title":"Hematology"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/bmt.2017.16","volume":"52","author":"M Kotrova","year":"2017","unstructured":"Kotrova M, Van Der Velden VHJ, Van Dongen JJM, Formankova R, Sedlacek P, Br\u00fcggemann M, et al. Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL. Bone Marrow Transplant. 2017;52:962\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.bbmt.2014.04.018","volume":"20","author":"AC Logan","year":"2014","unstructured":"Logan AC, Vashi N, Faham M, Carlton V, Kong K, Bu\u00f1o I, et al. Immunoglobulin and t cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival. Biol Blood Marrow Transplant. 2014;20:1307\u201313.","journal-title":"Biol Blood Marrow Transplant"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","volume":"120","author":"M Faham","year":"2012","unstructured":"Faham M, Zheng J, Moorhead M, Carlton VEH, Stow P, Coustan-Smith E, et al. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2012;120:5173\u201380.","journal-title":"Blood"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/leu.2013.52","volume":"27","author":"AC Logan","year":"2013","unstructured":"Logan AC, Zhang B, Narasimhan B, Carlton V, Zheng J, Moorhead M, et al. Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. Leukemia. 2013;27:1659\u201365.","journal-title":"Leukemia"},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"21194","DOI":"10.1073\/pnas.1118357109","volume":"108","author":"AC Logan","year":"2011","unstructured":"Logan AC, Gao H, Wang C, Sahaf B, Jones CD, Marshall EL, et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci USA. 2011;108:21194\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/leu.2013.375","volume":"28","author":"M Ladetto","year":"2014","unstructured":"Ladetto M, Br\u00fcggemann M, Monitillo L, Ferrero S, Pepin F, Drandi D, et al. Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. Leukemia. 2014;28:1299\u2013307.","journal-title":"Leukemia"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3324\/haematol.2016.155424","volume":"102","author":"D Wren","year":"2017","unstructured":"Wren D, Walker BA, Br\u00fcggemann M, Catherwood MA, Pott C, Stamatopoulos K, et al. Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing. Haematologica. 2017;102:e57\u2013e60.","journal-title":"Haematologica"},{"key":"499_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrg.2017.44","volume":"18","author":"SA Hardwick","year":"2017","unstructured":"Hardwick SA, Deveson IW, Mercer TR. Reference standards for next-generation sequencing. Nat Rev Genet. 2017;18:473\u201384.","journal-title":"Nat Rev Genet"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1128\/JCM.00949-16","volume":"54","author":"AS Gargis","year":"2016","unstructured":"Gargis AS, Kalman L, Lubin IM. Assuring the quality of next-generation sequencing in clinical microbiology and public health laboratories. J Clin Microbiol. 2016;54:2857\u201365.","journal-title":"J Clin Microbiol"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atg.2016.06.001","volume":"10","author":"C Endrullat","year":"2016","unstructured":"Endrullat C, Gl\u00f6kler J, Franke P, Frohme M. Standardization and quality management in next-generation sequencing. Appl Transl Genom. 2016;10:2\u20139.","journal-title":"Appl Transl Genom"},{"issue":"5","key":"499_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40291-017-0277-9","volume":"21","author":"Michaela Kotrova","year":"2017","unstructured":"Kotrova M, Trka J, Kneba M, Br\u00fcggemann M. Is next-generation sequencing the way to go for residual disease monitoring in acute lymphoblastic leukemia? Mol Diagn Ther. 2017;21:481\u201392.","journal-title":"Molecular Diagnosis & Therapy"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","volume":"125","author":"DM Kurtz","year":"2015","unstructured":"Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125:3679\u201387.","journal-title":"Blood"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1182\/blood-2014-12-615757","volume":"125","author":"Ma Pulsipher","year":"2015","unstructured":"Pulsipher Ma, Carlson C, Langholz B, Wall Da, Schultz KR, Bunin N, et al. IgH-V (D) J NGS-MRD measurement pre- and early post-allotransplant de fi nes very low- and very high-risk ALL patients. Blood. 2015;125:3501\u20139.","journal-title":"Blood"},{"issue":"10","key":"499_CR20","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.4049\/jimmunol.1602050","volume":"198","author":"Anton W. Langerak","year":"2017","unstructured":"Langerak AW, Br\u00fcggemann M, Davi F, Darzentas N, van Dongen JJM, Gonzalez D, et al. High-throughput immunogenetics for clinical and research applications in immunohematology: potential and challenges. J Immunol. 2017;198:3765\u20134.","journal-title":"The Journal of Immunology"},{"key":"499_CR21","doi-asserted-by":"crossref","unstructured":"Br\u00fcggemann M, Kotrova M, Knecht H, Bartram J, Boudjoghra M, Bystry, V et al. Next-generation sequencing of immunoglobulin and T-cell receptor gene rearrangements for MRD marker identification in acute lymphoblastic leukemia: a validation study by EuroClonality-NGS. Leukemia. 2019. In press.","DOI":"10.1038\/s41375-019-0496-7"},{"key":"499_CR22","doi-asserted-by":"crossref","unstructured":"Scheijen B, Meijers RW, Rijntjes J, van der Klift MY, M\u00f6bs M, Steinhilber J et al. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. Leukemia. 2019. In press.","DOI":"10.1038\/s41375-019-0508-7"},{"key":"499_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/bioinformatics\/btw634","volume":"33","author":"V Bystry","year":"2017","unstructured":"Bystry V, Reigl T, Krejci A, Demko M, Hanakova B, Grioni A, et al. ARResT\/Interrogate: an interactive immunoprofiler for IG\/TR NGS data. Bioinformatics. 2017;33:435\u20137.","journal-title":"Bioinformatics"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317.","journal-title":"Leukemia"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/sj.leu.2400887","volume":"11","author":"W Langerak a","year":"1997","unstructured":"Langerak a W, Szczepa\u0144ski T, Van Der Burg M, ILM Wolvers-Tettero, JJM VanDongen. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia. 1997;11:2192\u20139.","journal-title":"Leukemia"},{"key":"499_CR26","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368:1509\u201318.","journal-title":"N Engl J Med"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2016.11.009","volume":"53","author":"M Salson","year":"2017","unstructured":"Salson M, Giraud M, Caillault A, Grardel N, Duployez N, Ferret Y, et al. High-throughput sequencing in acute lymphoblastic leukemia: follow-up of minimal residual disease and emergence of new clones. Leuk Res. 2017;53:1\u20137.","journal-title":"Leuk Res"},{"issue":"4","key":"499_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/bjh.15002","volume":"183","author":"Hiroyuki Takamatsu","year":"2017","unstructured":"Takamatsu H, Wee RK, Zaimoku Y, Murata R, Zheng J, Moorhead M, et al. A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. Br J Haematol. 2017. https:\/\/doi.org\/10.1111\/bjh.15002 .","journal-title":"British Journal of Haematology"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2017-09-806521","volume":"131","author":"B Wood","year":"2018","unstructured":"Wood B, Wu D, Crossley B, Dai Y, Williamson D, Gawad C, et al. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL. Blood. 2018;131:1350\u20139.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0499-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0499-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-019-0499-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T17:31:18Z","timestamp":1694971878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0499-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0499-4","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The EuroClonality-NGS Working Group is an independent scientific subdivision of EuroClonality that aims at innovation, standardisation and education in the field of diagnostic clonality analysis. The revenues of the previously obtained patent (PCT\/NL2003\/000690), which is collectively owned by the EuroClonality Foundation and licensed to InVivoScribe, are exclusively used for EuroClonality activities, such as for covering costs of the Working Group meetings, collective WorkPackages and the EuroClonality Educational Workshops. MB: contract research for Affimed, Amgen, Regeneron, advisory board of Amgen, Incyte, Speaker bureau of Janssen, Pfizer, Roche; AWL: contract research for Roche-Genentech, research support from Gilead, advisory board for AbbVie, speaker for Gilead, Janssen; RG-S: research grants from Gilead, Takeda, Amgen and the Spanish government; and reports consulting fees from Janssen, Takeda, Incyte and BMS; KS: research support from Janssen, Abbvie, Gilead; speaker for Janssen, Abbvie, Gilead; advisory board for Janssen, Abbvie, Gilead; PG: speaker for Gilead. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}